Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2020 Oct 20;39:220. doi: 10.1186/s13046-020-01716-6

Correction to: The role of microRNA-133b and its target gene FSCN1 in gastric cancer

Lihua Guo 1,2,#, Hua Bai 3,#, Dongling Zou 4,#, Tao Hong 2, Jie Liu 1, Jiaqiang Huang 2, Pengfei He 5, Qi Zhou 4,, Jinsheng He 2,
PMCID: PMC7574269  PMID: 33081806

Correction to: J Exp Clin Cancer Res 33, 99 (2014)

https://doi.org/10.1186/s13046-014-0099-0

Following publication of the article [1], the authors identified errors in Figs. 3, 4 and 6; specifically panels Fig. 3c (HGC-27 ‘untreated’), Fig. 4c (GES ‘untreated’), Fig. 6c and d. The corrections do not change the results or the conclusions of this paper.

Fig. 3.

Fig. 3

Enforced expression of miR-133b can inhibit GC cell migration and invasion. (A) The pictures of wound healing and the percentages of open wound of HGC-27 cells at 0, 24, 48 hours after scratching. Data are shown as mean + s.d. (n = 3); ** indicates P-value <0.01. (B) The pictures of wound healing and the percentages of open wound of MGC-803 cells at 0, 24, 48 hours after scratching. Data are shown as mean + s.d. (n = 3); ** indicates P-value <0.01. (C) The invaded HGC-27 cells in the Matrigel transwell invasion assay. Data are shown as mean + s.d. (n = 3); ** indicates P-value <0.01. (D) The invaded MGC-803 cells in the Matrigel transwell invasion assay. Data are shown as mean + s.d. (n = 3); ** indicates P-value <0.01

Fig. 4.

Fig. 4

Knockdown of miR-133b in GES cells can promote cell proliferation and migration. (A) Inhibition of miR-133b in GES cells was confirmed by qRT-PCR. (B) The cell growth of GES cells at day 0, 1, 2, 3, 4 post transfection which was detected by CCK-8 assay. Data are shown as mean ± s.d. (n = 3); * indicates P-value <0.05;** indicates P-value <0.01. (C) The invaded GES cells in the Matrigel transwell invasion assay. Data are shown as mean + s.d. (n = 3); ** indicates P-value <0.01

Fig. 6.

Fig. 6

Knock down of FSCN1 can inhibit GC cell growth and invasion. (A) Western blot analysis of FSCN1 expression in HGC-27 and MGC-803 cells transfected with negative control or FSCN1 siRNAs. (B) The cell growth of HGC-27 and MGC-803 cells at day 0, 1, 2, 3, 4 post transfection which was detected by CCK-8 assay. Data are shown as mean + s.d. (n = 3); * indicates P-value <0.05. ** indicates P-value <0.01. *** indicates P-value <0.001. (C) The invaded HGC-27 cells in the Matrigel transwell invasion assay. Data are shown as mean + s.d. (n = 3); ** indicates P-value <0.01. (D) The invaded MGC-803 cells in the Matrigel transwell invasion assay. Data are shown as mean + s.d. (n = 3); ** indicates P-value <0.01. (E) Western blot analysis of FSCN1 expression in 6 pairs of GC tissues (C) and the adjacent non-neoplastic tissues (N)

Footnotes

Lihua Guo, Hua Bai and Dongling Zou contributed equally to this work.

Contributor Information

Qi Zhou, Email: qizhou9128@163.com.

Jinsheng He, Email: jshhe@bjtu.edu.cn.

Reference

  • 1.Guo L, Bai H, Zou D, et al. The role of microRNA-133b and its target gene FSCN1 in gastric cancer. J Exp Clin Cancer Res. 2014;33:99. doi: 10.1186/s13046-014-0099-0. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES